Titulo:
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
.
Guardado en:
0121-7372
2462-991X
32
2023-03-09
17
22
Revista Repertorio de Medicina y Cirugía - 2020
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98_article_1313 |
|---|---|
| record_format |
ojs |
| institution |
FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD |
| thumbnail |
https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png |
| country_str |
Colombia |
| collection |
Revista Repertorio de Medicina y Cirugía |
| title |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| spellingShingle |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida Matute Mizger, Vanesa Martínez Sánchez, Lina Maria Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological |
| title_short |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| title_full |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| title_fullStr |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| title_full_unstemmed |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| title_sort |
quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida |
| author |
Matute Mizger, Vanesa Martínez Sánchez, Lina Maria |
| author_facet |
Matute Mizger, Vanesa Martínez Sánchez, Lina Maria |
| topic |
Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological |
| topic_facet |
Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological |
| citationvolume |
32 |
| citationissue |
1 |
| publisher |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| ispartofjournal |
Revista Repertorio de Medicina y Cirugía |
| source |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313 |
| language |
|
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Repertorio de Medicina y Cirugía - 2020 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2023-03-09 |
| date_accessioned |
2023-03-09 17:41:07 |
| date_available |
2023-03-09 17:41:07 |
| url |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313 |
| url_doi |
https://doi.org/10.31260/RepertMedCir.01217372.1313 |
| issn |
0121-7372 |
| eissn |
2462-991X |
| doi |
10.31260/RepertMedCir.01217372.1313 |
| citationstartpage |
17 |
| citationendpage |
22 |
| url2_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2087 |
| url3_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2305 |
| url5_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2321 |
| url4_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2352 |
| url7_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2336 |
| _version_ |
1811201554359779328 |
| spelling |
Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida Matute Mizger, Vanesa Martínez Sánchez, Lina Maria Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological 32 1 Artículo de revista Journal article 2023-03-09 17:41:07 2023-03-09 17:41:07 2023-03-09 application/pdf text/html application/epub+zip text/xml audio/mpeg Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Revista Repertorio de Medicina y Cirugía 0121-7372 2462-991X https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313 10.31260/RepertMedCir.01217372.1313 https://doi.org/10.31260/RepertMedCir.01217372.1313 https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Repertorio de Medicina y Cirugía - 2020 17 22 Wang Z, Zhang R, Liu L, Shen Y, Chen J, Qi T, et al. Incidence and spectrum of infections among HIV/AIDS patients with lymphoma during chemotherapy. J Infect Chemother. 2021; (10):1459-64. doi: 10.1016/j.jiac.2021.06.012. 2. Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. 3. Ramorola BR, Goolam-Hoosen T, Alves de Souza Rios L, Mowla S. Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis. Genes (Basel). 2021;12(9):1302. doi:10.3390/genes12091302. 4. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018;378(11):1029-1041. doi: 10.1056/NEJMra1615896. 5. Antel K, Chetty D, Oosthuizen J, Mohamed Z, Van der Vyver L, Verburgh E. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. Pathology. 2021; 53(5):628-34. doi: 10.1016/j.pathol.2020.11.004. 6. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018; (11):1029-41. doi: 10.1056/NEJMra1615896. 7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. 8. Re A, Cattaneo C, Rossi G. Hiv and Lymphoma: from Epidemiology to Clinical Management. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019004. doi: 10.4084/MJHID.2019.004. 9. Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 ;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. 10. Shindiapina P, Pietrzak M, Seweryn M, McLaughlin E, Zhang X, Makowski M, et al. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial. Front Immunol. 2021;12:700045. doi: 10.3389/fimmu.2021.700045. 11. Navarro JT, Moltó J, Tapia G, Ribera JM. Hodgkin Lymphoma in People Living with HIV. Cancers (Basel). 2021 ;13(17):4366. doi: 10.3390/cancers13174366. 12. Horner MJ, Shiels MS, Pfeiffer RM, Engels EA. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015. Clin Infect Dis. 2021;72(9):e224-e231. doi: 10.1093/cid/ciaa1016. 13. Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020 ;7(9):e641-e651. doi: 10.1016/S2352-3018(20)30118-1. 14. Robbins HA, Shiels MS, Pfeiffer RM, Engels EA. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS. 2014 Mar ;28(6):881-90. doi: 10.1097/QAD.0000000000000163. 15. Strosberg C, Sagatys E. Primary anaplastic large cell lymphoma of the CNS as initial presentation of HIV infection: A case report. Human Pathology: Case reports. 2021; 24 (200493-523). 16. Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med. 2000 Sep 4;192(5):637-46. doi: 10.1084/jem.192.5.637. 17. Hanna J, Hossain GS, Kocerha J. The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019 May 16;10:478. doi: 10.3389/fgene.2019.00478. 18. Gebauer N, Witte HM, Merz H, Oschlies I, Klapper W, Caliebe A, Tharun L, Spielmann M, von Bubnoff N, Feller AC, Murga Penas EM. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021:bloodadvances.2021004635. doi: 10.1182/bloodadvances.2021004635. 19. Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, et al. Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 2018; 103(5):857-864. doi: 10.3324/haematol.2017.180893. 20. Casimiro LC, Mauro GP, Medici CTM, Weltman E. Survival and consolidative radiotherapy in patients living with HIV and treated for diffuse large B-cell lymphoma. Rep Pract Oncol Radiother. 2020; 25(6):956-960. doi: 10.1016/j.rpor.2020.09.004. 21. Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood. 2016; 128(8):1050-8. doi: 10.1182/blood-2015-08-664706. 22. Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005; 105(2):874-8. doi: 10.1182/blood-2004-04-1532. 23. Simonelli C, Zanussi S, Pratesi C, Rupolo M, Talamini R, Caffau C, et al. Immune Recovery After Autologous Stem Cell Transplantation Is Not Different for HIV-Infected Versus HIV-Uninfected Patients With Relapsed or Refractory Lymphoma. Clin Infect Dis. 2010; 50(12):1672–9. doi: 10.1086/652866 24. Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, et al. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk. Bone Marrow Transplant. 2018; 53(2):228-230. doi: 10.1038/bmt.2017.230. 25. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4. 26. De Matos A, Lopes SB, Serra JE, Ferreira E, da Cunha JS. Mortality predictive factors of people living with human immunodeficiency virus and bloodstream infection. Int J Infect Dis. 2021 Sep;110:195-203. doi: 10.1016/j.ijid.2021.06.032 27. Ortega M, Almela M, Soriano A, Marco F, Martínez JA, Muñoz A, Peñarroja G, Mensa J. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):969-76. doi: 10.1007/s10096-008-0531-5. 28. Ohmoto A, Fuji S. Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Rev. 2021;46:100738. doi: 10.1016/j.blre.2020.100738. 29. Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019;37(21):1790-1799. doi: 10.1200/JCO.18.01994. 30. Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018; 36(30):3043-3054. doi: 10.1200/JCO.18.00374. https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2087 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2305 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2321 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2352 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2336 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc http://purl.org/redcol/resource_type/ARTREV info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |